World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
24683
World Ranking
1963
National Ranking
73

Cécile Goujard publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Cécile Goujard sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 342 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Cécile Goujard D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Cécile Goujard sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Cécile Goujard is affiliated with the University of Paris-Saclay in France and has made substantial contributions to the field of medicine, primarily focusing on infectious diseases. Their research portfolio includes extensive work related to HIV/AIDS as well as autoimmune and viral diseases.

The main fields of study encompass Medicine, with specialized subfields in Infectious Diseases, Virology, Rheumatology, Emergency Medicine, and Neurology. Their work frequently addresses topics such as HIV Research and Treatment, HIV/AIDS Research and Interventions, HIV-related health complications and treatments, Systemic Lupus Erythematosus Research, HIV/AIDS drug development and treatment, Hepatitis C virus research, and Peripheral Neuropathies and Disorders.

Among recent and notable publications are:

  • Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1, 2021, The Journal of Experimental Medicine
  • Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta, 2020, Journal of Hepatology
  • Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case-control study with hydroxychloroquine blood-level analysis, 2020, Lara D. Veeken
  • CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies, 2020, Clinical Infectious Diseases
  • Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection, 2020, EBioMedicine

Cécile Goujard has frequently published in venues such as La Revue de Médecine Interne, AIDS, Journal of Hepatology, Clinical Infectious Diseases, and Journal of Antimicrobial Chemotherapy.

Their frequent coauthors include Laurence Meyer, Olivier Lambotte, Faroudy Boufassa, Olivier Bouchaud, and Asma Essat. The collaboration with these researchers indicates active engagement within networks focusing on infectious diseases and immunology.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.

    Asier Sáez-Cirión;Charline Bacchus;Laurent Hocqueloux;Véronique Avettand-Fenoel

  • Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

    Fabrice Carrat;Firouzé Bani-Sadr;Stanislas Pol;Eric Rosenthal

  • Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

    Caroline Charlier;Élodie Perrodeau;Alexandre Leclercq;Alexandre Leclercq;Benoît Cazenave

  • Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.

    M L Gougeon;H Lecoeur;A Dulioust;M G Enouf

  • Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.

    Sophie Grabar;Vincent Le Moing;Cécile Goujard;Catherine Leport

  • HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.

    Olivier Lambotte;Faroudy Boufassa;Yoann Madec;Ahn Nguyen

  • Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment

    Yves Levy;Christine Lacabaratz;Laurence Weiss;Jean-Paul Viard

  • Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

    Unknown

  • Reduced blood CD123 + (lymphoid) and CD11c + (myeloid) dendritic cell numbers in primary HIV-1 infection

    Jérôme Pacanowski;Sandrine Kahi;Marjorie Baillet;Pierre Lebon

  • Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study

    Y. Lévy;I. Sereti;G. Tambussi;J. P. Routy

  • Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.

    Paul Bastard;Paul Bastard;Paul Bastard;Elizaveta Orlova;Leila Sozaeva;Romain Lévy;Romain Lévy

  • CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection

    Jean-Marc Doisne;Alejandra Urrutia;Christine Lacabaratz-Porret;Cécile Goujard

  • Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy.

    O Lambotte;Y Taoufik;M G de Goër;C Wallon

  • CD4 Cell Count and HIV DNA Level Are Independent Predictors of Disease Progression after Primary HIV Type 1 Infection in Untreated Patients

    Cécile Goujard;Mojgan Bonarek;Laurence Meyer;Fabrice Bonnet

  • Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection.

    Xavier Monnet;Emmanuelle Vidal-Petiot;David Osman;Olfa Hamzaoui

  • Early Levels of HIV-1 DNA in Peripheral Blood Mononuclear Cells Are Predictive of Disease Progression Independently of HIV-1 RNA Levels and CD4+ T Cell Counts

    Christine Rouzioux;Jean-Baptiste Hubert;Marianne Burgard;Christiane Deveau

  • Impact of a patient education program on adherence to HIV medication: a randomized clinical trial.

    Cécile Goujard;Noëlle Bernard;Nathalie Sohier;Dominique Peyramond

  • Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study

    Cyril Dalmasso;Wassila Carpentier;Laurence Meyer;Christine Rouzioux

  • Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir.

    Nathalie Sagot-Lerolle;Aurelia Lamine;Marie-Laure Chaix;Faroudy Boufassa

  • Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients

    Fabrice Carrat;Firouzé Bani-Sadr;Stanislas Pol;Eric Rosenthal

Frequent Co-Authors

Jean-François Delfraissy
Jean-François Delfraissy National Ethical Consultative Committee for Life Sciences and Health
Olivier Lambotte
Olivier Lambotte University of Paris-Saclay
Christine Rouzioux
Christine Rouzioux Necker-Enfants Malades Hospital
Laurence Meyer
Laurence Meyer University of Paris-Saclay
Marie-Laure Chaix
Marie-Laure Chaix Université Paris Cité
Faroudy Boufassa
Faroudy Boufassa University of Paris-Saclay
Laurence Meyer
Laurence Meyer University of Utah
François Boué
François Boué University of Paris-Saclay
Alain Venet
Alain Venet Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, related online degree programs such as those in nursing and mental health can open diverse career opportunities. Many aspiring healthcare professionals consider the which nurse practitioner program is easiest to find a path that balances rigorous education with manageable coursework.

Specializations like psychiatric mental health nursing are gaining prominence. Prospective students often seek top pmhnp programs that offer excellent clinical placement rates, ensuring real-world experience alongside academic learning.

Cost is another major factor when choosing an online degree. Identifying the cheapest online pmhnp programs helps students obtain quality education without overwhelming financial burden.

Career prospects remain a key consideration post-graduation. Many graduates pursue Doctor of Nursing Practice (DNP) roles, and understanding how much do dnps make by state can guide decisions on specialization and location for maximum career benefit.

Best Scientists Citing Cécile Goujard

Trending Scientists

Recently Published Articles